The central government on Monday asked the Delhi High Court to vacate the interim stay on ban on some fixed dose combinations (FDC) medicines sold by pharma majors saying they "endanger patient safety".
The central government on Monday asked the Delhi High Court to vacate the interim stay on ban on some fixed dose combinations (FDC) medicines sold by pharma majors saying they "endanger patient safety".
The government on Monday launched Bedaquiline, an exclusive drug to tackle drug resistant TB cases in the country, among several other initiatives against the disease.
India's AYUSH Minister Sripad Yesso Naik on Sunday said the ministry will ink an agreement with the World Health Organization to popularise AYUSH system of medicine at a global level.
[adsense:336x280:8701650588]
Government included more 88 drugs, surgical and consumables in Jan Aushadhi Scheme to make more covers over different portfolios. Till now Jan Aushadhi stores includes total 488 medicines including - Anti-allergy, Anti-infective, Anti-cancer, Antidiabetic agents, Central Nervous System disease, Cardio Vascular Agents, Eye Nose throat product, Eye disease, Gastro Intestinal Tract disease, Harmone, Non Opoidal Anti Inflammatory Drugs, Non-Steroidal Anti Inflammatory Drugs, Nutrient, Respiratory disease, Skin disease, Vaccine, Vitamins & Minerals, Miscellaneous etc.
The Supreme Court asked the central government as to why it was not making functional or upgrading its own vaccines manufacturing units, and instead procuring the vaccines from the market.
Delhi high court gave temporary relief to Pfizer, Abbott and Macelods over health ministry's ban on certain fixed dose combinations (FDCs). The permit is provided till 21st march from governments ban on these companies products.
On the basis of the recommendations of the Expert Committee and in exercise of powers conferred by Drugs and Cosmetics Act, 1940, the Central Government banned the manufacture for sale, sale and distribution for human use of fixed dose combination of around 344 drugs.
The Indian drug regulators has withdrawn the alert on avastin which was imposed after off-label use of drug and recent cases of blindness. The office of DCG(I) was requested to take necessary measures to withdraw the Alert Notice issued on 21.01.2016 which was primarily issued as a precautionary measure in the light of the incidences of blindness reported in Gujarat.
The CPI-M on Thursday expressed deep concern that 76 life saving drugs have been taken off the customs duties exemption list and urged the government to review the decision.
The government will set up 3,000 new generic medicine stores across the country to tackle the shortage of drugs in rural areas, Finance Minister Arun Jaitley said on Monday.